NPI: 1417258245 · OAKLAND PARK, FL 33334 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 11/10/2010
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 11/10/2010 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 18,082 | $3.46M |
| 2019 | 24,036 | $5.09M |
| 2020 | 20,984 | $4.61M |
| 2021 | 7,191 | $541K |
| 2022 | 128 | $15K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 24,682 | 1,047 | $4.41M |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 18,185 | 1,231 | $3.56M |
| J1270 | Injection, doxercalciferol, 1 mcg | 13,775 | 918 | $2.70M |
| J1756 | Injection, iron sucrose, 1 mg | 4,557 | 859 | $916K |
| A4657 | Syringe, with or without needle, each | 3,221 | 1,158 | $766K |
| 85048 | 994 | 728 | $241K | |
| 85041 | 992 | 728 | $239K | |
| 83970 | 1,038 | 624 | $235K | |
| 83540 | 892 | 679 | $197K | |
| 83550 | 860 | 660 | $191K | |
| 82728 | 555 | 403 | $105K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 197 | 94 | $54K |
| 85045 | 219 | 157 | $46K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 76 | 62 | $17K |
| 82108 | 67 | 49 | $16K | |
| 82652 | 62 | 52 | $15K | |
| 82746 | 29 | 20 | $11K | |
| G0008 | Administration of influenza virus vaccine | 20 | 16 | $7K |